Xi-Wen Wu

Hyaluronic acid-based CeO₂ nanozymes for brain-targeted Parkinson's disease therapy: Biointerface design, multifunctional neuroprotective regulation and future perspectives: A review.

Parkinson's disease (PD) is a progressive neurodegenerative disorder driven by oxidative imbalance, mitochondrial dysfunction, and persistent neuroinflammation, yet current pharmacological interventions provide symptomatic relief but fail to halt neuronal degeneration largely owing to complex pathological mechanisms an...